We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Study of NP002 in Subjects With Idiopathic Parkinson's Disease to Treat Dyskinesias Due to Levodopa Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00957918
Recruitment Status : Completed
First Posted : August 13, 2009
Last Update Posted : October 5, 2011
Information provided by (Responsible Party):
Neuraltus Pharmaceuticals, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : September 2010
  Study Completion Date : September 2010
  Certification or Request for Extension to Delay Results Submission: September 26, 2011